About | Free Trial

Last Update

2015-10-19T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Jag Khalsa?

Dr. Jag Khalsa H.

Chief, Medical Consequences Branch

NIH Institutes

Direct Phone: (301) ***-****       

Email: j***@***.gov

NIH Institutes

5601 Fishers Lane, Rm 2F49

Rockville, Maryland 20852

United States

Company Description

The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basi... more

Find other employees at this company (27,327)

Background Information

Employment History

Chief, Medical Consequences Branch, Division of Pharmacotherapies and Medical Consequences of Drug Abuse
National Institute on Drug Abuse, NIH

Chief, Medical Consequences of Drug Abuse and Infections
US National Institutes of Health

Affiliations

Numerous Federal and NIH Level Committees
HHS Viral Hepatitis Implementation Group

Education

Master's degree
herbal pharmacology

Ph.D.

National Institute

Ph.D.
neuro-psycho-pharmacology
SK&F

Web References (59 Total References)


fairkids.com :: Marijuana Withdrawal Evidence

www.fairkids.com [cached]

Now, NIDA-supported researchers at McLean Hospital in Belmont, Massachusetts, and Columbia University in New York City have shown that individuals who regularly smoke marijuana experience withdrawal symptoms after they stop smoking the drug."These studies suggest that in real-world situations abstinence from daily marijuana smoking creates withdrawal symptoms similar to those of other drugs of abuse," says Dr. Jag Khalsa of NIDA's Center on AIDS and Other Medical Consequences of Drug Abuse.


6 Ways to Boost Your Mental Acuity At Work | Ririan Project

ririanproject.com [cached]

"We know a lot about the acute effects of marijuana use, but researchers are just now beginning to look at the long-term effects," says Dr. Jag Khalsa of NIDA's Center on AIDS and Other Medical Consequences of Drug Abuse.


Editorial Board Members | USG

blumsrewarddeficiencysyndrome.com [cached]

Dr. Jag Khalsa, with about 50 years of experience in drug research, serves as the Chief of the Medical Consequences Branch, National Institute on Drug Abuse, NIH, DHHS; is responsible for developing/administering a national and international program of clinical research on medical and health consequences of drug abuse and co-occurring infections (HIV, HCV, and others). Prior to joining NIDA in 1987, he served for ~10 yrs as a pharmacologist/toxicologist assessing safety (carcinogenic/teratogenic) potential of chemicals [INDs/NDAs] and food additives) and clinical evaluator at FDA. He has published in pharmacology, toxicology, epidemiology and medical journals. He serves on editorial boards of Journals of Addiction Medicine, Research on HIV/AIDS and Palliative Care, Frontiers of Neuroscience, and Clinical Infectious Diseases. He also serves on numerous Federal and NIH level committees including the HHS Viral Hepatitis Implementation Group (VHIG), National Commission on Digestive Diseases and its two sub-committees (Liver Research, Diabetes Research), Federal Task Force on TB, NIH Steering Committee on Centers for AIDS Research, and Human Microbiome Workgroup. He has received distinguished service awards from the FDA Commissioner, NIDA and NIH Directors, Society of Neuro-Immune-Pharmacology (SNIP), Life Time Achievement Awards from SNIP and International Conference on Molecular Medicine (India) and MIT, India; a commendation from the US Congress, Awards of Merit from the International Society of Addiction Medicine (ISAM), the President of the American Society of Addiction Medicine (ASAM), and a Certificate of Appreciation from the Office of Assistant Secretary for Health (Drs. Howard Koh and Ron Valdiserri), DHHS. He has a PhD in neuro-psycho-pharmacology, a Master's degree in herbal pharmacology, post-doctoral training in CNS/Cardiovascular pharmacology at SK&F, and Toxicology at SRI International. Jag Khalsa, MS, PhD


Dr. Jag H. Khalsa National ...

www.brightice.org [cached]

Dr. Jag H. Khalsa National Institute of Health, USA

...
Dr. Jag Khalsa, with 47+ years of experience in drug research, serves as the Chief of the Medical Consequences Branch, NIDA/NIH/DHHS, is responsible for developing/administering a national and international program of clinical research on medical and health consequences of drug abuse and co-occurring infections (HIV, HCV, and others). Prior to joining NIDA in 1987, he served for ~10 yrs as a pharmacologist/toxicologist assessing safety (carcinogenic/teratogenic) potential of chemicals [INDs/NDAs] and food additives) and clinical evaluator at FDA. He has published in pharmacology, toxicology, epidemiology and medical journals. He serves on editorial boards of Journals of Addiction Medicine, Research on HIV/AIDS and Palliative Care, Frontiers of Neuroscience, and Clinical Infectious Diseases. He has received distinguished service awards from the FDA Commissioner, NIDA and NIH Directors, Society of Neuro-Immune-Pharmacology (SNIP), Life Time Achievement Awards from International Conference on Molecular Medicine (India) and MIT, India; a commendation from the US Congress, Awards of Merit from the International Society of Addiction Medicine (ISAM), and the President of the American Society of Addiction Medicine (ASAM). He has a Ph.D. in neuro-psycho-pharmacology, post-doctoral trainings in CNS/Cardiovascular pharmacology at SK&F, and Toxicology at SRI International. BIOGRAPHY


Dr. Jag H. Khalsa National ...

brightice.org [cached]

Dr. Jag H. Khalsa National Institute of Health, USA

...
Dr. Jag Khalsa, with 47+ years of experience in drug research, serves as the Chief of the Medical Consequences Branch, NIDA/NIH/DHHS, is responsible for developing/administering a national and international program of clinical research on medical and health consequences of drug abuse and co-occurring infections (HIV, HCV, and others). Prior to joining NIDA in 1987, he served for ~10 yrs as a pharmacologist/toxicologist assessing safety (carcinogenic/teratogenic) potential of chemicals [INDs/NDAs] and food additives) and clinical evaluator at FDA. He has published in pharmacology, toxicology, epidemiology and medical journals. He serves on editorial boards of Journals of Addiction Medicine, Research on HIV/AIDS and Palliative Care, Frontiers of Neuroscience, and Clinical Infectious Diseases. He has received distinguished service awards from the FDA Commissioner, NIDA and NIH Directors, Society of Neuro-Immune-Pharmacology (SNIP), Life Time Achievement Awards from International Conference on Molecular Medicine (India) and MIT, India; a commendation from the US Congress, Awards of Merit from the International Society of Addiction Medicine (ISAM), and the President of the American Society of Addiction Medicine (ASAM). He has a Ph.D. in neuro-psycho-pharmacology, post-doctoral trainings in CNS/Cardiovascular pharmacology at SK&F, and Toxicology at SRI International. BIOGRAPHY

Similar Profiles

Other People with this Name

Other people with the name Khalsa

Amarjeet Khalsa

Punit Khalsa
Academy of Art University

Hari Singh Khalsa
Hari Simran Foundation

Gb Khalsa
Paper Trading Inc

Jaskirat Khalsa
M. Shapiro Real Estate Group

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory